Breast Imaging With Positron Emission Tomography and Fluorine-18 Fluorodeoxyglucose: Use and Limitations
Top Cited Papers
- 20 October 2000
- journal article
- clinical trial
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 18 (20) , 3495-3502
- https://doi.org/10.1200/jco.2000.18.20.3495
Abstract
PURPOSE: To evaluate the diagnostic value of positron emission tomography (PET) using fluorine-18 fluorodeoxyglucose (FDG) for the diagnosis of primary breast cancer. PATIENTS AND METHODS: Preopera...Keywords
This publication has 44 references indexed in Scilit:
- Oncological applications of positron emission tomography with fluorine-18 fluorodeoxyglucoseEuropean Journal of Nuclear Medicine and Molecular Imaging, 1996
- Assessment of Axillary Lymph Node Involvement in Breast Cancer Patients With Positron Emission Tomography Using Radiolabeled 2-(Fluorine-18)-fluoro-2-deoxy-D-glucoseJNCI Journal of the National Cancer Institute, 1996
- Report of the International Workshop on Screening for Breast CancerJNCI Journal of the National Cancer Institute, 1993
- Positron emission tomography with fluorine-18-deoxyglucose in the detection and staging of breast cancerCancer, 1993
- Invasive Lobular Carcinoma Imaging Features and Clinical DetectionInvestigative Radiology, 1993
- The Application of Positron Emission Tomographie Imaging With Fluorodeoxyglucose to the Evaluation of Breast DiseaseAnnals of Surgery, 1992
- Detection method, tumour size and node metastases in breast cancers diagnosed during a trial of breast cancer screeningEuropean Journal of Cancer and Clinical Oncology, 1987
- A FLUORINATED GLUCOSE ANALOG, 2-FLUORO-2-DEOXY-D-GLUCOSE (F-18)Journal of Computer Assisted Tomography, 1980
- On the Origin of Cancer CellsScience, 1956